Kimberly-Clark de Mexico SAB de CV (OTCMKTS:KCDMY) Issues Quarterly Earnings Results

Kimberly-Clark de Mexico SAB de CV (OTCMKTS:KCDMY - Get Free Report) announced its earnings results on Thursday. The basic materials company reported $0.20 EPS for the quarter, Zacks reports. Kimberly-Clark de Mexico SAB de CV had a net margin of 13.02% and a return on equity of 140.79%.Kimberly-Clark de Mexico SAB de CV Stock Up 3.6%Shares of KCDMY stock traded up $0.41 during trading hours on Thursday, hitting $11.65. 63,502 shares of the company's stock traded hands, compared to its average volume of 38,568. The company has a quick ratio of 0.97, a current ratio of 1.27 and a debt-to-equity ratio of 3.60. The stock's fifty day simple moving average is $10.54 and its two-hundred day simple moving average is $10.01. Kimberly-Clark de Mexico SAB de CV has a 12-month low of $7.14 and a 12-month high of $11.65. The stock has a market cap of $7.17 billion, a price-to-earnings ratio of 19.10 and a beta of 0.75. Analyst Upgrades and DowngradesSeparately, Itau BBA Securities raised Kimberly-Clark de Mexico SAB de CV from a "market perform" rating to an "outperform" rating in a report on Tuesday, November 4th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of "Buy".Get Our Latest Report on KCDMYKimberly-Clark de Mexico SAB de CV Company Profile (Get Free Report)Kimberly-Clark de México, SAB. de C.V. operates as one of the leading manufacturers of personal care and paper‐based products in Mexico. As a locally managed subsidiary of the global Kimberly-Clark Corporation, the company focuses on the production, marketing and distribution of consumer staples designed for everyday use, ranging from facial and bathroom tissue to diapers and feminine care items. The company's portfolio includes well-known brands such as Kleenex and Scott for tissue products, Huggies for baby care, Kotex for feminine hygiene and Depend for adult incontinence.See AlsoFive stocks we like better than Kimberly-Clark de Mexico SAB de CVThe Crash Has Already Started (Most Just Don’t See It Yet)Trump’s AI Secret: 100X Faster Than NvidiaNew gold price targetTrump Planning to Use Public Law 63-43: Prepare NowA U.S. “birthright” claim worth trillions - activated quietlyThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Kimberly-Clark de Mexico SAB de CV Right Now?Before you consider Kimberly-Clark de Mexico SAB de CV, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark de Mexico SAB de CV wasn't on the list.While Kimberly-Clark de Mexico SAB de CV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here